Trial ID: | L2559 |
Source ID: | NCT00879710
|
Associated Drug: |
Simvastatin Or Ezetimibe
|
Title: |
Effect of Diabetes Mellitus on Cholesterol Metabolism
|
Acronym: |
|
Status: |
COMPLETED
|
Study Results: |
YES
|
Results: |
https://ClinicalTrials.gov/show/NCT00879710/results
|
Conditions: |
Type 1 Diabetes Mellitus|Type 2 Diabetes Mellitus|Hypercholesterolemia
|
Interventions: |
DRUG: simvastatin or ezetimibe
|
Outcome Measures: |
Primary: Changes in LDL Cholesterol, Subjects with T1DM or T2DM were assigned to alternating therapy with simvastatin (40 mg) or ezetimibe (10 mg) for 6 weeks in a crossover design. The data are reported as follows. Subjects with type 1 diabetes mellitus: Simvastatin: Changes in LDL after 6-week therapy with simvastatin (irrespective of the treatment order) Ezetimibe: Changes in LDL after 6-week therapy with ezetimibe (irrespective of the treatment order) Subjects with type 2 diabetes mellitus: Simvastatin: Changes in LDL after 6-week therapy with simvastatin (irrespective of the treatment order) Ezetimibe: Changes in LDL after 6-week therapy with ezetimibe (irrespective of the treatment order), 6 weeks after starting drug therapy | Secondary: Changes in Cholesterol Absorption or Synthesis Rates From the Baseline, Our plan was to measure changes in cholesterol absorption and synthesis rates from the baseline after 6 weeks of statin or ezetimibe therapy., 6 weeks after initiation of drug therapy
|
Sponsor/Collaborators: |
Sponsor: Medical College of Wisconsin
|
Gender: |
ALL
|
Age: |
ADULT, OLDER_ADULT
|
Phases: |
|
Enrollment: |
57
|
Study Type: |
INTERVENTIONAL
|
Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
Start Date: |
2008-08
|
Completion Date: |
2013-07
|
Results First Posted: |
2016-04-18
|
Last Update Posted: |
2020-07-29
|
Locations: |
Medical College of Wisconsin /Froedtert Hospital, Milwaukee, Wisconsin, 53226, United States
|
URL: |
https://clinicaltrials.gov/show/NCT00879710
|